Crinetics Pharmaceuticals Inc. (CRNX)
Market Closed
17 Jul, 20:00
$
83. 86
-0.05
-0.0596%
$
8.88B Market Cap
- P/E Ratio
- Div Yield
5.37M Volume
-3.64 Eps
$ 83.91
Previous Close 
Want to track CRNX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Misses Revenue Estimates
Crinetics Pharmaceuticals, Inc. (CRNX) came out with a quarterly loss of $0.94 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to loss of $0.94 per share a year ago.
Zacks | 1 year ago
Crinetics Pharmaceuticals, Inc. (CRNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Crinetics Pharmaceuticals (CRNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks | 1 year ago
